These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5549137)

  • 1. [Tolbutamide therapy of fatty liver].
    Wildhirt E
    Med Welt; 1971 Mar; 10():383-7. PubMed ID: 5549137
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tolbutamide and steatosis. Trial on the rat].
    Barthe J; Grimaud JA
    Pathol Biol (Paris); 1970 Mar; 18(5):255-9. PubMed ID: 4911312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current problems of fatty liver].
    Knick B
    Dtsch Med J; 1968 May; 19(10):389-94. PubMed ID: 4889933
    [No Abstract]   [Full Text] [Related]  

  • 4. [Letter: Tolbutamide therapy of fatty liver?].
    Mehnert H
    Med Klin; 1973 Sep; 68(38):1240. PubMed ID: 4746851
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of tolbutamide on the fatty liver of diabetics].
    Lange HJ; Knick B; Kössling FK; Kremer GJ; Beringer A; Hrabal ; Irsigler K; Thaler H
    Dtsch Med Wochenschr; 1968 Jul; 93(29):1412-6. PubMed ID: 5658748
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behaviour of liver function tests and enzymes in various stages of fatty liver under long-term treatment with Tolbutamide].
    Schmitt W
    Med Welt; 1968 Apr; 16():1060-5. PubMed ID: 5703103
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatic steatosis in diabetics. The place of dolipol in its treatment].
    Journ Annu Diabetol Hotel Dieu; 1968; 9():423-6. PubMed ID: 5748223
    [No Abstract]   [Full Text] [Related]  

  • 8. [The behavior of glucose, pyruvic acid and nonesterified fatty acids following i.v. tolbutamide loading in fatty liver].
    Teichmann W; Bchardt U
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):217-20. PubMed ID: 5732400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on the differentiation of diabetic and hepatogenic fatty liver].
    Jorke D; Unbehaun G
    Z Gesamte Inn Med; 1971 Nov; 26(21):Suppl:289-91. PubMed ID: 5149918
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nonalcoholic fatty liver disease and insulin resistance: clinical, biochemical, and morphological parallels].
    Zvenigorodskaia LA; Drozdov VN; Egorova EG
    Eksp Klin Gastroenterol; 2008; (3):25-30. PubMed ID: 19145879
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of tolbutamide on the diabetic fatty liver.
    Beringer A; Hrabal I; Irsigler K; Thaler H
    Ger Med Mon; 1968 Dec; 13(12):595-8. PubMed ID: 4898499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fatty liver in latent diabetes].
    Kühnav J
    Dtsch Med Wochenschr; 1972 Mar; 97(12):485. PubMed ID: 5017399
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N; Qi Y; Patel HR; Ahima RS
    J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative relations between sero-chemical findings, fatty degeneration of the liver, alcohol drinking and body weight in a diabetic and non-diabetic collective with fatty degeneration of the liver].
    Fuchs T; Immich H; Nedden R
    Med Welt; 1971 Mar; 10():392-9. PubMed ID: 5549139
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of cynarin on fatty liver].
    Eberhardt G
    Z Gastroenterol; 1973 Apr; 11(3):183-6. PubMed ID: 4803418
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and prognosis of fatty liver].
    Wittman I; Trebitsch M
    Wien Z Inn Med; 1967; 48(5):203-7. PubMed ID: 5620281
    [No Abstract]   [Full Text] [Related]  

  • 17. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
    Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
    Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis--a histological perspective.
    Sakhuja P; Malhotra V
    Indian J Pathol Microbiol; 2006 Apr; 49(2):163-72. PubMed ID: 16933708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new experimental approach in the study of chronic alcoholism. I. Effects of high alcohol intake in rats fed a commercial laboratory diet.
    Porta EA; Gomez-Dumm CL
    Lab Invest; 1968 Apr; 18(4):352-64. PubMed ID: 5689655
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy for nonalcoholic fatty liver disease.
    Moseley RH
    J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.